| Description | Blosozumab (LY2541546), an anti-sclerostin (SOST) antibody, promotes bone formation while decreasing bone resorption, with potential applications in osteoporosis research [1] [2]. |
| In vivo | Blosozumab（按1-100毫克/公斤剂量，静脉注射）在大鼠中表现出诱导骨过生的效应[1]。 |
| molecular weight | N/A |
| CAS | 1132758-87-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |